Abstract
these patients, the indications for fentanyl use, the transmucosal route used for fentanyl administration, the dose of fentanyl given, the frequency of use, and the effectiveness of the medication in managing symptoms. Methods/session descriptions. Information about the logistical issues encountered in implementing this practice will be highlighted. These included establishing a guideline for the availability of the medication, the use of an atomizer in nasal medication delivery, and supporting staff in this approach to managing symptoms in neonates at end of life. Conclusion. This session/poster will present the findings of a retrospective chart review on the use and effectiveness of intranasal fentanyl in palliative symptom management of newborns and infants. Practitioners in perinatal and pediatric palliative care will gain an understanding of how this novel approach can be implemented in their practice.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
